Reports
Sale
Global Hydroxychloroquine and Chloroquine Market Size, Price, Share, Forecast: By Strength: 100mg, 200mg, 250mg, 500mg; By Grade: USP Standards Grade, EP Standards Grade, Others; By Dosage Form; By Route of Administration; By Applications; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032
Global Hydroxychloroquine and Chloroquine Market Outlook
The global hydroxychloroquine and chloroquine market size attained a value of USD 1.84 million in 2023, driven by its rising application in the treatment of malaria. The market is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032, likely to attain a value of USD 3.85 million by 2032.
Hydroxychloroquine and Chloroquine: Introduction
Hydroxychloroquine and chloroquine are antimalarial medicines that are used to treat malaria. These medicines were frequently used by healthcare professionals during the COVID-19 pandemic as these were showing positive results in treating the virus when no other medicines were working. Other than coronavirus, the increased cases of malaria got these drugs to get popular especially around pandemic. Hydroxychloroquine is generally used in the treatment of autoimmune diseases, such as rheumatoid arthritis and systematic lupus erythematosus.
SLE Hydroxychloroquine helps in enhancing the performance of immune system and reduces inflammation as well. Chloroquine has been in existence from a long time, but it was never given such important before the pandemic. Chloroquine drug is generally used in treating malaria but it protects patients against malaria caused from parasite. It does so by stopping the growth of malarial parasite in the human body.
Global Hydroxychloroquine and Chloroquine Market Analysis
Due to the high demand for hydroxychloroquine and chloroquine drugs, especially during the COVID-19 pandemic, the rate of manufacturing of these drugs has increased in the last few years. Additionally, due to the discovery of these drugs as a potential treatment for coronavirus, there are many research going on to explore the potential of hydroxychloroquine and chloroquine in other medical conditions as well. Owing to the several research still being in process, the governments have put certain safety guidelines over the regulation and consumptions of these drugs, such as no consumption should be performed without a consultation with a healthcare professional. The potential rise in the use of the medication in the treatment of other diseases is anticipated to propel the hydroxychloroquine and chloroquine market expansion.
Global Hydroxychloroquine and Chloroquine Market Segmentations
Market Breakup by Strength
- 100mg
- 200mg
- 250mg
- 500mg
Market Breakup by Grade
- USP Standards Grade
- EP Standards Grade
- Pharmaceutical Standards Grade
- Others
Market Breakup by Dosage Form
- Tablet
- Injectables
Market by Route of Administration
- Oral
- Intravenous
Hydroxychloroquine and Chloroquine Market Breakup by Applications
- Rheumatoid Arthritis
- Malaria
- COVID-19
- Others
Market Breakup by End User
- Hospitals
- Speciality Clinics
- Homecare
- Others
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Hydroxychloroquine and Chloroquine Market Overview
The increased demand for the drugs, owing to its application in the treatment of malaria and especially in the treatment of coronavirus, has been primarily driving the demand. There are specific guidelines regarding the usage of hydroxychloroquine and chloroquine by the government as there are multiple research that are being conducted to validate the fact that they might actually be effective in other medical conditions other than malaria and COVID-19. The hydroxychloroquine and chloroquine drug market development has been running steadily but ever since COVID-19 happened, there has been a huge surge in the demand for these drugs in the global market. The global hydroxychloroquine and chloroquine market is expected to grow in coming years as well.
Global Hydroxychloroquine and Chloroquine Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Ipca Laboratories Ltd.
- Zydus Cadila
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- Rising Pharma Holdings Inc.
- Abcam plc.
- Mylan N.V.
- Abbott Laboratories
- Artecef B.V.
- Uniprix Inc.
- Recipharm
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Strength |
|
| Breakup by Grade |
|
| Breakup by Dosage Form |
|
| Breakup by Route of Administration |
|
| Breakup by Applications |
|
| Breakup by End User |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Hydroxychloroquine and Chloroquine Market Overview
3.1 Global Hydroxychloroquine and Chloroquine Market Historical Value (2017-2023)
3.2 Global Hydroxychloroquine and Chloroquine Market Forecast Value (2024-2032)
4 Global Hydroxychloroquine and Chloroquine Market Landscape
4.1 Global Hydroxychloroquine and Chloroquine Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Hydroxychloroquine and Chloroquine Product Landscape
4.2.1 Analysis by Strength
4.2.2 Analysis by Indications
4.2.3 Analysis by Route of Administration
5 Global Hydroxychloroquine and Chloroquine Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Hydroxychloroquine and Chloroquine Market Segmentation
6.1 Global Hydroxychloroquine and Chloroquine Market by Strength
6.1.1 Market Overview
6.1.2 100mg
6.1.3 200mg
6.1.4 250mg
6.1.5 500mg
6.2 Global Hydroxychloroquine and Chloroquine Market by Grade
6.2.1 Market Overview
6.2.2 USP Standards Grade
6.2.3 EP Standards Grade
6.2.4 Pharmaceutical Standards Grade
6.2.5 Others
6.3 Global Hydroxychloroquine and Chloroquine Market by Dosage Form
6.3.1 Market Overview
6.3.2 Tablet
6.3.3 Injectables
6.4 Global Hydroxychloroquine and Chloroquine Market by Route of Administration
6.4.1 Market Overview
6.4.2 Oral
6.4.3 Intravenous
6.5 Global Hydroxychloroquine and Chloroquine Market by Applications
6.5.1 Market Overview
6.5.2 Rheumatoid Arthritis
6.5.3 Malaria
6.5.4 COVID-19
6.5.5 Others
6.6 Global Hydroxychloroquine and Chloroquine Market by End User
6.6.1 Market Overview
6.6.2 Hospitals
6.6.3 Speciality Clinics
6.6.4 Homecare
6.6.5 Others
6.7 Global Hydroxychloroquine and Chloroquine Market by Distribution Channel
6.7.1 Market Overview
6.7.2 Hospital Pharmacy
6.7.3 Retail Pharmacy
6.7.4 Online Pharmacy
6.7.5 Others
6.8 Global Hydroxychloroquine and Chloroquine Market by Region
6.8.1 Market Overview
6.8.2 North America
6.8.3 Europe
6.8.4 Asia Pacific
6.8.5 Latin America
6.8.6 Middle East and Africa
7 North America Hydroxychloroquine and Chloroquine Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Hydroxychloroquine and Chloroquine Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Hydroxychloroquine and Chloroquine Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Hydroxychloroquine and Chloroquine Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Hydroxychloroquine and Chloroquine Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Ipca Laboratories Ltd.
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Zydus Cadila
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Novartis AG
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Teva Pharmaceutical Industries Ltd.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 Bayer AG
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 Rising Pharma Holdings Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Abcam plc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Mylan N.V.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 Abbott Laboratories
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 Artecef B.V.
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
17.11 Uniprix Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisition
17.11.5 Certifications
17.12 Recipharm
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisition
17.12.5 Certifications
18 Global Hydroxychloroquine and Chloroquine Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of USD 1.84 million in 2023, driven by its rising uses in the treatment of malaria.
The market size is anticipated to grow at a CAGR of 8.5% during the forecast period of 2024-2032, likely to attain a value of USD 3.85 million by 2032.
The growth of the market is driven by factors like rising healthcare sector, rising investment by the government in healthcare development, and the rising use of the drug in malaria treatment, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa.
The different strengths of these drugs in the market are 100mg, 200mg, 250mg, and 500mg.
The different grades in the global market are USP standards grade, EP standards grade, and pharmaceutical standards grade, among others.
The different forms of dosages are injectables and tablets.
The different applications in the market are rheumatoid arthritis, malaria, and COVID-19, among others.
The different route of administration in the market includes oral and intravenous.
The different end users are hospitals, specialty clinics, and homecare, among others.
The different distribution channels in the market are hospital pharmacy, retail pharmacy, and online pharmacy, among others.
The governments have put certain safety guidelines over the regulation and consumptions of these drugs, which is a key trend for the market.
Key players involved in the market are Ipca Laboratories Ltd., Zydus Cadila, Novartis AG, Teva Pharmaceutical Industries Ltd., Bayer AG, Rising Pharma Holdings Inc., Abcam plc., Mylan N.V., Abbott Laboratories, Artecef B.V., Uniprix Inc., and Recipharm.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER